Synthesis and biological evaluation of 2,3-diarylimidazo[1,2-a]pyridines as antileishmanial agents
Models, Molecular
Pyridines
[SDV]Life Sciences [q-bio]
Casein kinase 1
2
Antiprotozoal Agents
Antineoplastic Agents
Direct arylation
01 natural sciences
Structure-Activity Relationship
Parasitic Sensitivity Tests
615
Lipophilicity
[CHIM] Chemical Sciences
[CHIM]Chemical Sciences
Humans
Protein Kinase Inhibitors
Protein Kinase C
Antileishmanial activity 2
Cell Proliferation
Leishmania major
Dose-Response Relationship, Drug
Molecular Structure
Casein Kinase I
Antileishmanial activity
540
0104 chemical sciences
3. Good health
[SDV] Life Sciences [q-bio]
[SDV.TOX] Life Sciences [q-bio]/Toxicology
Antileishmanial activity 2 3-Diarylimidazo[1 2-a]pyridines Direct arylation Lipophilicity Casein kinase 1
[SDV.TOX]Life Sciences [q-bio]/Toxicology
3-Diarylimidazo[1
[SDV.SP.PHARMA] Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology
[SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology
2-a]pyridines Direct arylation Lipophilicity Casein kinase 1
Drug Screening Assays, Antitumor
2-a]pyridines
HeLa Cells
DOI:
10.1016/j.ejmech.2012.10.048
Publication Date:
2012-11-02T21:31:59Z
AUTHORS (11)
ABSTRACT
A novel series of 2,3-diarylimidazo[1,2-a]pyridines was synthesized and evaluated for their antileishmanial activities. Four derivatives exhibited good activity against the promastigote and intracellular amastigote stages of Leishmania major, coupled with a low cytotoxicity against the HeLa human cell line. The impact of compound lipophilicity on antiparasitic activities was investigated by Log D comparison. Although LmCK1 could be the parasitic target for three compounds (13, 18, 21), the inhibition of another target is under study to explain the antileishmanial effect of the most promising compounds.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (36)
CITATIONS (61)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....